Health Catalyst PE Ratio 2018-2025 | HCAT
Current and historical p/e ratio for Health Catalyst (HCAT) from 2018 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Health Catalyst PE ratio as of July 18, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Health Catalyst PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-18 | 3.65 | 0.00 | |
| 2025-03-31 | 4.53 | $-1.15 | 0.00 |
| 2024-12-31 | 7.07 | $-1.15 | 0.00 |
| 2024-09-30 | 8.14 | $-1.35 | 0.00 |
| 2024-06-30 | 6.39 | $-1.50 | 0.00 |
| 2024-03-31 | 7.53 | $-1.85 | 0.00 |
| 2023-12-31 | 9.26 | $-2.10 | 0.00 |
| 2023-09-30 | 10.12 | $-2.23 | 0.00 |
| 2023-06-30 | 12.50 | $-2.68 | 0.00 |
| 2023-03-31 | 11.67 | $-2.72 | 0.00 |
| 2022-12-31 | 10.63 | $-2.66 | 0.00 |
| 2022-09-30 | 9.70 | $-2.94 | 0.00 |
| 2022-06-30 | 14.49 | $-2.92 | 0.00 |
| 2022-03-31 | 26.13 | $-3.10 | 0.00 |
| 2021-12-31 | 39.62 | $-3.21 | 0.00 |
| 2021-09-30 | 50.01 | $-3.28 | 0.00 |
| 2021-06-30 | 55.51 | $-3.14 | 0.00 |
| 2021-03-31 | 46.77 | $-3.05 | 0.00 |
| 2020-12-31 | 43.53 | $-2.87 | 0.00 |
| 2020-09-30 | 36.60 | $-2.25 | 0.00 |
| 2020-06-30 | 29.17 | $-2.97 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.261B | $0.307B |
| Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.177B | 57.48 |
| Doximity (DOCS) | United States | $11.570B | 53.56 |
| Hims & Hers Health (HIMS) | United States | $11.189B | 116.26 |
| Tempus AI (TEM) | United States | $10.500B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.334B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.774B | 58.97 |
| Hinge Health (HNGE) | United States | $3.628B | 0.00 |
| Privia Health (PRVA) | United States | $2.525B | 172.58 |
| Enovis (ENOV) | United States | $1.763B | 9.83 |
| Schrodinger (SDGR) | United States | $1.589B | 0.00 |
| Phreesia (PHR) | United States | $1.543B | 0.00 |
| 10x Genomics (TXG) | United States | $1.533B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.532B | 0.00 |
| Azenta (AZTA) | United States | $1.470B | 68.32 |
| Evolent Health (EVH) | United States | $1.323B | 112.70 |
| Omnicell (OMCL) | United States | $1.310B | 23.12 |
| Claritev (CTEV) | United States | $0.733B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.552B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.457B | 0.00 |
| Talkspace (TALK) | United States | $0.422B | 126.00 |
| TruBridge (TBRG) | United States | $0.328B | 728.33 |
| Outset Medical (OM) | United States | $0.312B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.282B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.250B | 0.00 |
| CapsoVision (CV) | United States | $0.218B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.107B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 3.98 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |